Perioperative changes in left ventricular systolic function following surgical revascularization.

Pubmed ID: 36355812

Pubmed Central ID: PMC9648779

Journal: PloS one

Publication Date: Nov. 10, 2022

MeSH Terms: Humans, Male, Female, Aged, Middle Aged, Clinical Trials as Topic, Treatment Outcome, Stroke Volume, Coronary Artery Bypass, Ventricular Function, Left, Ventricular Dysfunction, Left, Myocardial Ischemia

Authors: Adabag S, Carlson S, Gravely A, Buelt-Gebhardt M, Naksuk N, Downey MC, Hooks M, Tholakanahalli V

Cite As: Downey MC, Hooks M, Gravely A, Naksuk N, Buelt-Gebhardt M, Carlson S, Tholakanahalli V, Adabag S. Perioperative changes in left ventricular systolic function following surgical revascularization. PLoS One 2022 Nov 10;17(11):e0277454. doi: 10.1371/journal.pone.0277454. eCollection 2022.

Studies:

Abstract

BACKGROUND: Nearly 1/3rd of patients undergoing coronary artery bypass graft surgery (CABG) have left ventricular systolic dysfunction. However, the extent, direction and implications of perioperative changes in left ventricular ejection fraction (LVEF) have not been well characterized in these patients. METHODS: We studied the changes in LVEF among 549 patients with left ventricular systolic dysfunction (LVEF <50%) who underwent CABG as part of the Surgical Treatment for Ischemic Heart Failure (STICH) trial. Patients had pre- and post-CABG (4 month) LVEF assessments using identical cardiac imaging modality, interpreted at a core laboratory. An absolute change of >10% in LVEF was considered clinically significant. RESULTS: Of the 549 patients (mean age 61.4±9.55 years, and 72 [13.1%] women), 145 (26.4%) had a >10% improvement in LVEF, 369 (67.2%) had no change and 35 (6.4%) had >10% worsening of LVEF following CABG. Patients with lower preoperative LVEF were more likely to experience an improvement after CABG (odds ratio 1.36; 95% CI 1.21-1.53; per 5% lower preoperative LVEF; p <0.001). Notably, incidence of postoperative improvement in LVEF was not influenced by presence, nor absence, of myocardial viability (25.5% vs. 28.3% respectively, p = 0.67). After adjusting for age, sex, baseline LVEF, and NYHA Class, a >10% improvement in LVEF after CABG was associated with a 57% lower risk of all-cause mortality (HR: 0.43, 95% CI: 0.26-0.71). CONCLUSIONS: Among patients with ischemic cardiomyopathy undergoing CABG, 26.4% had >10% improvement in LVEF. An improvement in LVEF was more likely in patients with lower preoperative LVEF and was associated with improved long-term survival.